Biliary tract cancer stem cells - translational options and challenges

doi:10.3748/wjg.v23.i14.2470

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 23, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (10753)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-2) series.

Item

Count

PDF

639

WORD

505

HTML

5272

Figures (1-1)

286

Tables (1-2)

215

Sum=6917

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

567

Download

845

Sum=1412

Publishing Process of This Article

Item

Count

Browse

986

Download

1438

Sum=2424

Apr 14, 2017 (publication date) through Nov 22, 2024

Times Cited of This Article

Times Cited (12)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Gastroenterol. Apr 14, 2017; 23(14): 2470-2482
Published online Apr 14, 2017. doi: 10.3748/wjg.v23.i14.2470

Open in New Tab Full Size Figure Download Figure

Figure 1 Cancer stem cells in biliary tract cancer. Biliary tract cancer stem cells are thought to originate from various subpopulations of healthy cells that harbor stem cell or stem cell-like traits. Currently available data on clinical biliary tract cancer (BTC) specimens revealed up-regulation of established cancer stem cells (CSC) cell surface and functional markers as well as aberrant activity of signaling pathways and micro-RNA species. Expression of CSC markers and stemness factors in BTC tissues is associated with diverse unfavorable clinico-pathological features and poor prognosis. See text for details.

Citation: Mayr C, Ocker M, Ritter M, Pichler M, Neureiter D, Kiesslich T. Biliary tract cancer stem cells - translational options and challenges. World J Gastroenterol 2017; 23(14): 2470-2482
URL: https://www.wjgnet.com/1007-9327/full/v23/i14/2470.htm
DOI: https://dx.doi.org/10.3748/wjg.v23.i14.2470